AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy.
Business Wire › October 17, 2006
Linked as:
Extract
AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy.
Conference call begins October 18 at 8:30 a.m. Eastern time
QUEENSBURY, N.Y. -- AngioDynamics, Inc. (NASDAQ:ANGO) announces the signing of an agreement to acquire Oncobionic, Inc., a privately held company that has developed an irreversible electroporation (IRE) soft tissue ablation technology intended for use in targeted, or focal, cancer and benign tumor t...See the full content of this document
Sponsored links
